Segall Bryant & Hamill’s Herbalife HLF Stock Holding History

Segall Bryant & Hamill’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-61,533	Closed	-$793K	–	609
2025 Q4	$793K	Buy	+61,533	New	+$652K	0.01%	522

Other funds holding HLF

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Segall Bryant & Hamill's HLF Position: Q1 2026 in Review

Segall Bryant & Hamill sold out of Herbalife (HLF) in Q1 2026, closing a stake of 61,533 shares — an estimated $793K sold.

Segall Bryant & Hamill first reported a position in HLF in Q4 2025 and held it in 1 quarter. The position peaked at $793K in Q4 2025. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

Segall Bryant & Hamill reported no remaining Herbalife position as of Q1 2026 after selling out during the quarter.
Segall Bryant & Hamill sold 61,533 Herbalife shares in Q1 2026, an estimated $793K.
Segall Bryant & Hamill first reported a position in Herbalife in Q4 2025 and held it in 1 quarter.
Segall Bryant & Hamill's Herbalife position peaked at $793K in Q4 2025.
252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.